The Daily Telegraph

Scientists plan to grow GM crops that could oil the wheels of industry

British researcher­s apply for permission to begin trials but campaigner­s fear food chain contaminat­ion

- By Sarah Knapton SCIENCE EDITOR

GM CROPS to produce industrial products could be grown after scientists applied for permission to start trials in British fields.

Rothamsted Research in Harpenden, Herts, wants to plant GM camelina with altered DNA so it produces “wax esters”, a natural lubricant that can be used on machinery in place of petrochemi­cals.

Until now the firm has only planted GM crops for human consumptio­n, such as camelina with extra Omega-3 fish oil to boost health, or altered wheat to produce higher yields.

The company said it planned to use camelina as a “chassis” to make useful lipids, or fatty acids, which can provide alternativ­es to chemicals in industrial applicatio­ns. But campaigner­s claim the outdoor trials in Herts and Suffolk pose an “unacceptab­le risk to people, wildlife and the wider environmen­t”.

Twenty-six organisati­ons including farmers, scientists, retailers and environmen­talists have objected, asking Defra to refuse permission for the trial. Some warned that pollen or seeds could escape and lead to other plants growing wax esters, which they claimed could be harmful to humans.

Liz O’neill, director of GM Freeze, which opposes the patenting of genetic resources, said: “Rothamsted Research started off trying to persuade us that GM camelina would save the oceans but now they’re referring to it as a ‘chassis’ on which they will produce an array of industrial compounds.

“GM Freeze wants to help create a world in which everyone’s food is produced responsibl­y, fairly and sustainabl­y. This trial would be a step in the opposite direction and should not go ahead.” Rothamsted, which has been geneticall­y altering plants for 15 years, submitted its applicatio­n in February and objections can be lodged until April 8, with a decision expected from Defra by the end of May. The company said it hoped to begin planting this year, completing trials by 2020.

Prof Jonathan Napier, leading the trial said: “We have synthesise­d the gene sequences involved in the production of Omega-3s and other useful compounds, such as astaxanthi­n and wax esters, and optimised them to be functional in camelina plants. These synthetic sequences are based on the sequence of genes found in a range of different organisms, including photosynth­etic marine organisms and other lower eukaryote species, such as mosses and oomycetes.

“By using transgenic camelina as a chassis to make these useful lipids, we have an alternativ­e source for them.”

As well as wax esters and Omega-3 alteration­s the plants could also be geneticall­y altered to increase stem thickness and boost crop yields.

 ??  ?? Prof Jonathan Napier with a small crop of GM camelina, which in its natural state has been cultivated in Europe for centuries
Prof Jonathan Napier with a small crop of GM camelina, which in its natural state has been cultivated in Europe for centuries

Newspapers in English

Newspapers from United Kingdom